Tracing how a study drug moves through healthy men
This study gives healthy people a single shot of a study drug that has a tiny radioactive label, then tracks how it moves through the body. It helps researchers learn how the drug is absorbed and removed, which is a key step before it can be tested as a possible treatment for weight-related conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy man aged 18 to 55 years.
- Your weight must be at least 110 pounds (50 kg) and your body mass index (BMI) must be between 20 and 35.
- You must agree to use effective birth control for 6 months after the study drug and not donate sperm during that time.
- You must not have had any low blood sugar episodes in the past year.
- You must be able to avoid smoking more than 5 cigarettes a day for 3 months before the study, and stop smoking entirely during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks if a new injectable medication (RAY1225) behaves the same in the body as the original version. It is for healthy adults and will compare the two forms to make sure they are alike.
This study examines how a new drug (called HRS-1780) is processed and eliminated by the body using a special radioactive label. It will help researchers understand the drug’s behavior to guide future studies.
This study gives healthy men a single dose of a new medicine to see how the body absorbs, uses, and removes it over time. It helps researchers understand the drug's safety and behavior before it is tested in patients.
This study gives healthy volunteers a small, safe dose of a radiolabeled (radioactive) drug to see how it is absorbed, broken down, and removed from the body. By participating, you help researchers understand the drug's behavior, which informs future dosing and safety.
This study tracks how a new drug, called FXS4640, moves through the body in healthy men. It uses a small amount of radioactivity to follow the drug, which helps researchers understand how it is absorbed and cleared. Participation involves staying at the clinic for several days for tests and samples.
This study is for healthy men to see how a new experimental drug moves through the body and leaves it. The drug contains a tiny amount of radiation, which helps researchers track it safely.
Hear when a new Basic Science trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.